Explore more publications!

Nepal Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.

Press releases published on March 18, 2026

OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights
AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors
AIMイムノテック、アンプリジェンとチェックポイント阻害剤を併用する新規がん治療法の、日本における特許の最終承認を発表
RenovoRx Announces $10 Million at Market Private Placement
Diabetes Canada launches Aprons in Action presented by Manulife
Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available
WallabyPhenox Restructures Debt and Accelerates Global Growth
SS Innovations’ SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
Equillium to Participate in the 38th Annual Roth Conference
TOMI Environmental Solutions Disrupts Food Safety Sector with 95% Reduction in Sanitation Testing Costs
Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
Prenetics to Participate in the 38th Annual ROTH Conference
Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren’s Syndrome
Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe
Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study
Akari Therapeutics Announces Abstract Accepted for Poster Presentation at the American Association for Cancer Research Annual Meeting 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions